Henkel KGaA Valuation
Is HEN3 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
4/6Valuation Score 4/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of HEN3 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: HEN3 (€79.1) is trading below our estimate of fair value (€154.06)
Significantly Below Fair Value: HEN3 is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for HEN3?
Key metric: As HEN3 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.
| What is HEN3's PE Ratio? | |
|---|---|
| PE Ratio | 18.6x |
| Earnings | €1.78b |
| Market Cap | €31.07b |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 1.5x |
| Enterprise Value/EBITDA | 8.4x |
| PEG Ratio | 2.9x |
Price to Earnings Ratio vs Peers
How does HEN3's PE Ratio compare to its peers?
| Company | Forward PE | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 31.3x | ||
BEI Beiersdorf | 37.4x | 12.7% | €27.6b |
RKT Reckitt Benckiser Group | 21.4x | 11.3% | UK£33.0b |
CHD Church & Dwight | 49.1x | 18.0% | US$26.7b |
KMB Kimberly-Clark | 17.4x | 2.2% | US$44.7b |
HEN3 Henkel KGaA | 18.6x | 6.5% | €31.1b |
Price-To-Earnings vs Peers: HEN3 is good value based on its Price-To-Earnings Ratio (18.6x) compared to the peer average (31.3x).
Price to Earnings Ratio vs Industry
How does HEN3's PE Ratio compare vs other companies in the Global Household Products Industry?
| 2 Companies | Price / Earnings | Estimated Growth | Market Cap |
|---|---|---|---|
| 2 Companies | Estimated Growth | Market Cap | |
|---|---|---|---|
Price-To-Earnings vs Industry: HEN3 is expensive based on its Price-To-Earnings Ratio (18.6x) compared to the Global Household Products industry average (17.2x).
Price to Earnings Ratio vs Fair Ratio
What is HEN3's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PE Ratio | 18.6x |
| Fair PE Ratio | 25.5x |
Price-To-Earnings vs Fair Ratio: HEN3 is good value based on its Price-To-Earnings Ratio (18.6x) compared to the estimated Fair Price-To-Earnings Ratio (25.5x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
| Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
|---|---|---|---|---|---|---|---|
| Current | €79.10 | €84.00 +6.2% | 6.7% | €95.00 | €73.00 | n/a | 19 |
| Nov ’25 | €79.44 | €85.06 +7.1% | 5.9% | €95.00 | €77.00 | n/a | 18 |
| Oct ’25 | €81.96 | €83.79 +2.2% | 7.8% | €95.00 | €67.00 | n/a | 19 |
| Sep ’25 | €82.76 | €83.84 +1.3% | 7.9% | €95.00 | €67.00 | n/a | 19 |
| Aug ’25 | €78.28 | €83.42 +6.6% | 8.1% | €95.00 | €67.00 | n/a | 19 |
| Jul ’25 | €83.14 | €81.68 -1.8% | 7.9% | €94.00 | €67.00 | n/a | 19 |
| Jun ’25 | €83.12 | €81.32 -2.2% | 7.9% | €94.00 | €67.00 | n/a | 19 |
| May ’25 | €74.46 | €74.37 -0.1% | 9.0% | €87.00 | €61.00 | n/a | 19 |
| Apr ’25 | €74.50 | €73.37 -1.5% | 9.9% | €87.00 | €60.00 | n/a | 19 |
| Mar ’25 | €70.40 | €73.35 +4.2% | 10.1% | €87.00 | €60.00 | n/a | 20 |
| Feb ’25 | €70.74 | €73.30 +3.6% | 10.1% | €87.00 | €60.00 | n/a | 20 |
| Jan ’25 | €72.86 | €72.65 -0.3% | 10.8% | €87.00 | €59.00 | n/a | 20 |
| Dec ’24 | €72.98 | €72.25 -1.0% | 10.6% | €87.00 | €59.00 | n/a | 20 |
| Nov ’24 | €68.48 | €71.11 +3.8% | 11.0% | €89.00 | €59.00 | €79.44 | 19 |
| Oct ’24 | €67.46 | €71.63 +6.2% | 10.9% | €89.00 | €59.00 | €81.96 | 19 |
| Sep ’24 | €71.18 | €71.75 +0.8% | 11.0% | €89.00 | €59.00 | €82.76 | 20 |
| Aug ’24 | €69.58 | €70.35 +1.1% | 11.6% | €87.00 | €58.00 | €78.28 | 20 |
| Jul ’24 | €73.26 | €69.95 -4.5% | 11.8% | €87.00 | €58.00 | €83.14 | 20 |
| Jun ’24 | €74.50 | €69.75 -6.4% | 12.4% | €87.00 | €55.00 | €83.12 | 20 |
| May ’24 | €73.28 | €68.16 -7.0% | 12.1% | €83.00 | €52.00 | €74.46 | 19 |
| Apr ’24 | €72.06 | €66.27 -8.0% | 13.7% | €83.00 | €48.40 | €74.50 | 20 |
| Mar ’24 | €68.60 | €65.97 -3.8% | 14.2% | €86.00 | €48.40 | €70.40 | 20 |
| Feb ’24 | €65.28 | €66.02 +1.1% | 14.3% | €86.00 | €48.40 | €70.74 | 20 |
| Jan ’24 | €65.02 | €66.27 +1.9% | 13.7% | €86.00 | €48.40 | €72.86 | 20 |
| Dec ’23 | €68.84 | €66.78 -3.0% | 13.9% | €89.00 | €48.40 | €72.98 | 21 |
| Nov ’23 | €63.36 | €66.30 +4.6% | 13.2% | €89.00 | €48.40 | €68.48 | 21 |
Analyst Forecast: Target price is less than 20% higher than the current share price.
Discover undervalued companies
L'Oréal
€175.0b
Through its subsidiaries, manufactures and sells cosmetic products for women and men worldwide.
LOR
€325.35
7D
-3.8%
1Y
-22.8%
Reynolds Consumer Products
US$5.7b
Produces and sells products in cooking, waste and storage, and tableware product categories in the United States and internationally.
3ZT
US$25.40
7D
1.6%
1Y
5.8%
McBride
UK£172.7m
Manufactures and sells private label household and personal care products to retailers and brand owners in the United Kingdom, Germany, France, Italy, Spain, rest of Europe, Asia-Pacific, and internationally.It operates through five segments: Liquids, Powders, Unit dosing, Aerosols, and Asia Pacific.
10W
UK£1.14
7D
-14.3%
1Y
71.4%